Results 121 to 130 of about 49,723 (153)

Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial. [PDF]

Nat Commun
Capdevila J, Hernando J, Molina-Cerillo J, Plana Serrahima M, Taberna Sanz M, Castelo B, Álvarez-Escolá C, Carmona-Bayonas A, Ballester Navarro I, Iglesias L, Bover M, Garcia-Alvarez A, Lavernia J, Yayá Tur R, Ruiz S, Baste N, Lorenzo-Lorenzo I, Sanchez-Hernandez A, Sanz-Garcia E, Marquina G, Nuciforo P, Elguero B, Grande E, Alonso-Gordoa T.   +23 more
europepmc   +1 more source

Pheochromocytoma/paraganglioma type 5 syndrome as a cause of secondary hypertension in a Colombian patient: case report [PDF]

Biomedica
Morales J, Arturo D, Folleco M.
europepmc   +1 more source

NON-FUNCTIONING SPORADIC PANCREATIC NEUROENDOCRINE TUMOR IS AN INDEPENDENT RISK FACTOR FOR RECURRENCE AFTER SURGICAL TREATMENT. [PDF]

Arq Bras Cir Dig
Figueira ERR, Montagnini AL, Okubo J, Fernandes AGV, Pereira MA, Ribeiro Junior U, Herman P, Jukemura J.   +7 more
europepmc   +1 more source

[Retroperitoneal schwannoma mimicking colorectal cancer metastases: a false positive result report.] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Del Valle JB, Campana JP, Valeo Chulvi MP, Roitman PD.   +3 more
europepmc   +1 more source

Central pancreatectomy: a Latin American experience of parenchyma-sparing surgery for benign and low-grade pancreatic neoplasms. [PDF]

Arq Bras Cir Dig
Conde-Monroy D, Namur GN, Tustumi F, Stolzemburg LCP, Jureidini R, Jukemura J, Ribeiro Junior U, Herman P, Ribeiro TC.   +8 more
europepmc   +1 more source

Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer. [PDF]

Br J Cancer
Rubio-Cuesta B, Carretero-Puche C, Llamas P, Sarmentero J, Gil-Calderon B, Lens-Pardo A, Antón-Pascual B, Rubio-González E, Cámara-Jurado M, Salamanca J, Rueda-Fernández D, Delcuratolo MD, Soldevilla B, Garcia-Carbonero R.   +13 more
europepmc   +1 more source

Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study. [PDF]

Oncologist
Del Olmo-García M, Hernandez-Rienda L, Garcia-Carbonero R, Hernando J, Custodio A, Anton-Pascual B, Gomez M, Palma Milla S, Suarez L, Bellver M, Alonso V, Serrano R, Valdés N, Melian M, Febrero B, Sampedro-Nuñez MA, Biarnes J, Díaz-Pérez JÁ, Molina-Cerrillo J, Lopez C, Martínez Olmos MÁ, Merino-Torres JF, Capdevila J, Argente Pla M, NUTRIGETNE Group.   +24 more
europepmc   +1 more source

ROBOTIC PANCREATICODUODENECTOMY FOR THE TREATMENT OF A MIXED NEUROENDOCRINE-NON-NEUROENDOCRINE NEOPLASM (MINEN) OF THE AMPULLA OF VATER. [PDF]

Arq Bras Cir Dig
Surjan RCT, Paulino JFA, Schleinstein HP, Pereira FMT, Figueira ERR, Ardengh JC.   +5 more
europepmc   +1 more source

Optimized deep learning-accelerated single-breath-hold abdominal HASTE with and without fat saturation improves and accelerates abdominal imaging at 3 Tesla. [PDF]

BMC Med Imaging
Tan Q, Kubicka F, Nickel D, Weiland E, Hamm B, Geisel D, Wagner M, Walter-Rittel TC.   +7 more
europepmc   +1 more source

Malignant Small Bowel Neoplasms: A 20-Year Retrospective Analysis in a Tertiary Center. [PDF]

GE Port J Gastroenterol
Ferreira AT, Mesquita J, Rocha M, Marcos-Pinto R, Pedroto I, Salgado M.   +5 more
europepmc   +1 more source